1
Choung U Kim, John C Martin, Bing Y Luh, Peter F Misco: Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives. Bristol Myers Squibb Company, Michelle A Kaye, May 4, 1993: US05208221 (24 worldwide citation)

The present invention concerns nucleotide analogs and their compositions and use. In particular it relates to novel (phosphonomethoxy) methoxy purine/pyrimidine derivatives.


2
Choung U Kim, John C Martin, Bing Y Luh, Peter F Misco: Antiviral (phosphonomethoxy)methoxy purine/pyrimidine derivatives. Institute of Organic Chemistry and Biochemistry of the Academy of Science of the Czech Republic, Rega Stichting v z w, Daryl D Muenchau, January 31, 1995: US05386030 (18 worldwide citation)

The present invention concerns nucleotide analogs and their compositions and use. In particular it relates to novel (phosphonomethoxy) methoxy purine/pyrimidine derivatives.


3
Joanne J Bronson, Stanley V D Andrea, Shelley E Hoeft, John D Matiskella, Peter F Misco Jr, Bing Y Luh, Dane M Springer, Yasutsugu Ueda, John A Wichtowski: Cephalosporin derviatives. Bristol Myers Squibb Company, David M Morse, April 15, 1997: US05620969 (11 worldwide citation)

Novel cephem derivatives represented by the general formula ##STR1## in which the Acyl substituent is a group of the formula ##STR2## wherein Ar is a lipophilic optionally substituted phenyl, naphthyl or pyridyl group; R.sup.1 represents either the residue of a heterocyclic amino acid or a C.sub.2 - ...


4
Choung U Kim, Bing Y Luh, Peter F Misco: Thymidine derivatives and therapeutic method of use. Bristol Myers Squibb Company, William T Han, April 26, 1994: US05306722 (3 worldwide citation)

Thymidine kinase inhibitor of formula I ##STR1## in which R is C.sub.1-6 alkyl or AR(CH.sub.2).sub.n --, wherein Ar represents phenyl optionally substituted with one to five same or different halogen, C.sub.1-6 alkyl or C.sub.1-6 alkyloxy; and n equals one to six.


5
Dane M Springer, Bing Y Luh, Stanley V D Andrea, Thomas W Hudyma, Oak K Kim: Cephalosporin derivatives. Marla J Mathias, Bristol Myers Squibb Company, April 25, 2002: US20020049191-A1

The present invention provides a novel series of cephem derivatives of the general formula I 1 wherein R1, R2, R3, R5, R6, R7, A, L1, X, n and n are as defined herein above. The compounds of formula I are antibacterial agents useful in the treatment of infections in humans and other animals caused b ...


6


Click the thumbnails below to visualize the patent trend.